Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles

Fig. 3

(A) The expression of CD80 and CD206 on various macrophage phases detected by CLSM (scale bar: 20 μm). (B) Quantitative analysis of CD80 fluorescence intensity on various macrophage phases (***P < 0.001). (C) Quantitative analysis of CD206 fluorescence intensity on various macrophage phases (***P < 0.001). (D) Cell viabilities of M0 macrophage treated with HMMDN@PM or HMMDN-Met@PM. (E) Cell viabilities of M1 macrophage treated with HMMDN@PM or HMMDN-Met@PM. (F) Cell viabilities of M2 macrophage treated with HMMDN@PM or HMMDN-Met@PM

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us